plumbagin has been researched along with Familial Primary Pulmonary Hypertension in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barrier, M; Bonnet, P; Bonnet, S; Bonnet, SN; Courboulin, A; Jacob, MH; Lambert, C; Paulin, R; Perreault, T; Provencher, S; Tremblay, E; Tremblay, VL | 1 |
1 other study(ies) available for plumbagin and Familial Primary Pulmonary Hypertension
Article | Year |
---|---|
Plumbagin reverses proliferation and resistance to apoptosis in experimental PAH.
Topics: Animals; Apoptosis; Bone Morphogenetic Protein Receptors, Type II; Calcium; Cardiotonic Agents; Cell Proliferation; Cells, Cultured; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; In Situ Nick-End Labeling; Interleukin-6; Male; Muscle, Smooth, Vascular; Naphthoquinones; NFATC Transcription Factors; Potassium Channels, Voltage-Gated; Proliferating Cell Nuclear Antigen; Rats; rho-Associated Kinases | 2012 |